Table 5.
Patients | Total (n = 25) | Survival, n (%) | Mean Survival, Months | P Value |
---|---|---|---|---|
Sex | ||||
Female | 14 | 6 (42.9) | 180.2 | 0.027, NS |
Male | 11 | 3 (27.3) | 89.2 | |
Preexisting disease | ||||
No | 8 | 1 (12.5) | 83.2 | 0.053, NS |
Yes | 17 | 8 (47.1) | 173.6 | |
Cirrhosis | ||||
No | 10 | 1 (10) | 97.5 | 0.065, NS |
Yes | 15 | 8 (53.3) | 178.1 | |
Location | ||||
Unilobar | 13 | 4 (30.8) | 154.5 | 0.885, NS |
Bilobar | 12 | 5 (41.7) | 125.2 | |
Number | ||||
Single | 8 | 3 (37.5) | 179.8 | 0.436, NS |
Multiple | 17 | 6 (35.3) | 123.8 | |
Nodes | ||||
No | 21 | 9 (42.9) | 163.1 | 0.022 |
Yes | 4 | 0 (0.0) | 43.6 | |
Vascular invasion | ||||
No | 14 | 8 (57.1) | 218.9 | <0.001 |
Yes | 11 | 1 (9.1) | 46.6 | |
Metastasis | ||||
No | 25 | 9 (36.0) | 142.4 | NA |
Yes | 0 | 0 (0.0) | NA | |
Margin | ||||
Negative | 23 | 8 (34.8) | 142.7 | 0.951, NS |
Positive | 2 | 1 (50) | 72.0 | |
Incidental | ||||
No | 15 | 3 (20) | 91.1 | 0.011 |
Yes | 10 | 6 (60) | 222.8 | |
Stage I | 6 | 2 (33.3) | 186.8 | <0.001 |
Stage II | 10 | 7 (70) | 229.9 | |
Stage III | 5 | 0 (0.0) | 14.3 | |
Stage IV | 4 | 0 (0.0) | 43.6 |